55.7 F
San Diego
Tuesday, Mar 19, 2024
-Advertisement-

Vaccination Collaboration: Inovio Teams Up With NIH

DNA vaccine developer Inovio Biomedical has entered into a research collaboration agreement with the National Institutes of Health’s Vaccine Research Center to develop influenza vaccines, it said Aug. 10.

Financial details of the arrangement were not disclosed.

Under the agreement, the VRC and Inovio will pool technologies to develop universal flu vaccines and push development of vaccine candidates targeting the H1N1 swine flu strains. The collaboration will test Inovio’s method for delivering vaccines into the body, using a brief electrical pulse to permeate cell membranes.

Successful preclinical studies could lead to further clinical development, Inovio said.

, Heather Chambers

-Advertisement-

Featured Articles

-Advertisement-
-Advertisement-

Related Articles

-Advertisement-
-Advertisement-
-Advertisement-